Skip to main content
. Author manuscript; available in PMC: 2022 Mar 1.
Published in final edited form as: J ECT. 2021 Mar 1;37(1):40–45. doi: 10.1097/YCT.0000000000000714

Table 2:

sample size, gender ratio, mean age, mean seizure threshold, and titration protocol for previous studies utilizing right unilateral UBP ECT. In total the studies include 810 patients.

Paper N % female Age (yr) SD ST (mC) SD Titration protocol
Sackeim et al 200810 22 55.0% 54.0 16.0 22.0 8.0 not stated; 1 pt at 4.8 mC, rest at 19.2 or 38.4 mC
Sienaert et al 200919 32 71.9% 54.4 13.1 38.4 24.9 starting at 24 mC
McCormick et al 200920 26 73.0% 53.2 14.5 51.4 108.7 not stated
Roepke et al 201121 17 55.0% 54.3 15.5 37.5 12.1 not stated; group 1 of trial
Roepke et al 201121 17 65.0% 57.9 14.3 40.6 26.2 not stated; group 2 of trial
Quante et al 201122 41 76.8% 56.4 13.9 13.9 15.1 MECTA starting at 9.2 mC
van Waarde et al 201223 63 62.6% 59.1 15.0 45.6 16.8 Thymatron starting at 25.2 mC for pt < 50; 50.4 mC for patients >50
Rosa et al 201324 30 60.0% 52.0 15.2 36.1 15.1 MECTA table starting at 9.6 mC
Spaans et al 201325 58 70.7% 60.4 16.3 23.9 10.2 MECTA table starting at 9.6 mC
Mayur et al 201326 17 52.9% 43.4 11.7 22.1 8.9 MECTA table starting at 9.6 mC
Galvez et al 201511 179 60.9% 45.7 14.7 31.7 22.2 MECTA table starting at 9.6 mC or Thymatron 10 mC
Kellner et al 201613 240 57.5% 69.9 7.6 30.5 14.3 MECTA starting at 24 mC or Thymatron starting at 5% (25 mC)
Rasmussen at al 201627 20 80.0% 47.7 12.9 32.7 17.8 Thymatron starting at 5% (25 mC)
Galvez et al 201728 35 51.4% 50.2 15.6 27.7 11.5 MECTA table starting at 9.6 mC or Thymatron 10 mC
Wong et al 201929 13 23.1% 20.3 12.6 39.2 28.8 Thymatron, titration not stated